CA
PVLA

Cliff Asness’s Palvella Therapeutics PVLA Stock Holding History

Cliff Asness’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$354K Buy
+2,316
New +$281K ﹤0.01% 3549
2021
Q2 		– Sell
-612
Closed -$126K – 2309
2021
Q1 		$126K Sell
612
-620
-50% -$136K ﹤0.01% 2147
2020
Q4 		$246K Sell
1,232
-304
-20% -$63.2K ﹤0.01% 2031
2020
Q3 		$254K Sell
1,536
-667
-30% -$152K ﹤0.01% 1979
2020
Q2 		$546K Sell
2,203
-57
-3% -$13.3K ﹤0.01% 1710
2020
Q1 		$412K Buy
2,260
+2,046
+956% +$516K ﹤0.01% 1655
2019
Q4 		$62K Buy
+214
New +$59.3K ﹤0.01% 2102
2019
Q3 		– Sell
-445
Closed -$167K – 2179
2019
Q2 		$167K Sell
445
-104
-19% -$31K ﹤0.01% 1996
2019
Q1 		$147K Sell
549
-1,105
-67% -$263K ﹤0.01% 2108
2018
Q4 		$352K Sell
1,654
-77
-4% -$23.9K ﹤0.01% 1906
2018
Q3 		$775K Sell
1,731
-803
-32% -$349K ﹤0.01% 1797
2018
Q2 		$1.03M Sell
2,534
-2,663
-51% -$1.27M ﹤0.01% 1709
2018
Q1 		$2.83M Buy
5,197
+2,132
+70% +$1.32M ﹤0.01% 1211
2017
Q4 		$1.85M Buy
3,065
+2,159
+238% +$1M ﹤0.01% 1412
2017
Q3 		$417K Buy
+906
New +$387K ﹤0.01% 1999

Other funds holding PVLA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Cliff Asness's PVLA Position: Q2 2026 in Review

Cliff Asness opened a new position in Palvella Therapeutics (PVLA) in Q2 2026: 2,316 shares worth $354K. The stake represents ﹤0.01% of the portfolio and ranks #3549 among its holdings. This is a return to the name: Cliff Asness previously reported a position in PVLA as recently as Q1 2021.

Cliff Asness first reported a position in PVLA in Q3 2017 and has held it in 15 quarters since. The position peaked at $2.83M in Q1 2018. 196 funds tracked by Wall St. Rank hold PVLA as of Q2 2026.

  • Cliff Asness held 2,316 shares of Palvella Therapeutics worth $354K as of Q2 2026.
  • Palvella Therapeutics was a new Cliff Asness position in Q2 2026.
  • Palvella Therapeutics made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3549 holding.
  • Cliff Asness first reported a position in Palvella Therapeutics in Q3 2017 and has held it in 15 quarters since.
  • Cliff Asness's Palvella Therapeutics position peaked at $2.83M in Q1 2018.
  • 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.